These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33623385)

  • 1. Erratum: Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer's Disease [Corrigendum].
    Neuropsychiatr Dis Treat; 2021; 17():513. PubMed ID: 33623385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy: Erratum.
    Chen ML; Hong CG; Yue T; Li HM; Duan R; Hu WB; Cao J; Wang ZX; Chen CY; Hu XK; Wu B; Liu HM; Tan YJ; Liu JH; Luo ZW; Zhang Y; Rao SS; Luo MJ; Yin H; Wang YY; Xia K; Tang SY; Xie H; Liu ZZ
    Theranostics; 2021; 11(20):9774. PubMed ID: 34815784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum].
    Int J Gen Med; 2022; 15():2215-2216. PubMed ID: 35250299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Epigenetic mechanisms in Alzheimer's disease [Corrigendum].
    Degener Neurol Neuromuscul Dis; 2014; 4():131. PubMed ID: 32673378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: PPARĪ³ Agonist-Loaded PLGA-PEG Nanocarriers as a Potential Treatment for Alzheimer's Disease: In vitro and in vivo Studies [Corrigendum].
    Int J Nanomedicine; 2023; 18():3641-3642. PubMed ID: 37427369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum].
    Int J Nanomedicine; 2020; 15():8293-8294. PubMed ID: 33149576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum:
    Onco Targets Ther; 2020; 13():10761. PubMed ID: 33116649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum: Increased central auditory gain in 5xFAD Alzheimer's disease mice as an early biomarker candidate for Alzheimer's disease diagnosis.
    Na D; Zhang J; Beaulac HJ; Piekna-Przybylska D; Nicklas PR; Kiernan AE; White PM
    Front Neurosci; 2023; 17():1250244. PubMed ID: 37534037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Serum Secreted Protein Acidic and Rich in Cysteine-Like 1 as a Biochemical Predictor for Prognosticating Clinical Outcomes After Acute Supratentorial Intracerebral Hemorrhage: A Prospective Cohort Study [Corrigendum].
    Neuropsychiatr Dis Treat; 2024; 20():1179-1180. PubMed ID: 38827638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Effects of Creative Expression Therapy for Older Adults with Mild Cognitive Impairment at Risk of Alzheimer's Disease: A Randomized Controlled Clinical Trial [Corrigendum].
    Clin Interv Aging; 2023; 18():1827-1829. PubMed ID: 37929229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Performance of the Arabic Population on the Adolescent-Adult Sensory Profile: An Observational Study [Corrigendum].
    Neuropsychiatr Dis Treat; 2020; 16():837. PubMed ID: 32280224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Maternal and Paternal Depression During Pregnancy in China: Prevalence, Correlates, and Network Analysis [Corrigendum].
    Neuropsychiatr Dis Treat; 2021; 17():2527. PubMed ID: 34376981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Literature Overview of the Relation Between Psoriasis and Alzheimer [Corrigendum].
    Neuropsychiatr Dis Treat; 2023; 19():2519-2520. PubMed ID: 38029044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Impact of Supporting People with Advanced Parkinson's Disease on Carer's Quality of Life and Burden [Corrigendum].
    Neuropsychiatr Dis Treat; 2021; 17():67-68. PubMed ID: 33469293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Neural Correlates of Cognitive Dysfunction in Conditional Reasoning in Schizophrenia: An Event-Related Potential Study [Corrigendum].
    Neuropsychiatr Dis Treat; 2024; 20():835-836. PubMed ID: 38601068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Current Perception Threshold Testing in Pharyngeal Paresthesia Patients with Depression or Anxiety [Corrigendum].
    Neuropsychiatr Dis Treat; 2020; 16():1145. PubMed ID: 32440129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Gait and Balance Disorder in Patients with Transient Ischemic Attack or Minor Stroke [Corrigendum].
    Neuropsychiatr Dis Treat; 2022; 18():1269-1270. PubMed ID: 35784515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: A Predictive Model Offor Attention Deficit Hyperactivity Disorder Based on Clinical Assessment Tools [Corrigendum].
    Neuropsychiatr Dis Treat; 2020; 16():1943. PubMed ID: 32982242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum].
    Neuropsychiatr Dis Treat; 2021; 17():3135-3136. PubMed ID: 34703233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Assessments of Amino Acids, Ammonia and Oxidative Stress Among Cohort of Egyptian Autistic Children: Correlations with Electroencephalogram and Disease Severity [Corrigendum].
    Neuropsychiatr Dis Treat; 2020; 16():325. PubMed ID: 32099368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.